A
Alivus Life Sciences
ALIVUS Share Price
Healthcare949.75
as on 11 Mar 2026 at 15:29
Market Cap
₹11,652 Cr
PE Ratio
21.20
ROCE
22.32%
ALIVUS Fundamentals
Company Valuation
Market Cap (₹ Cr.)
11,652
PE Ratio
21.20
PB Ratio
3.82
Dividend Yield
0.53%
ROE
17.24%
ROCE
22.32%
Book Value (₹)
245.68
Face Value (₹)
2.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 75.00% | 74.99% | 74.94% | 74.91% | 74.91% |
| Domestic Institutional Investors (DII) | 4.86% | 5.19% | 5.61% | 5.47% | 7.12% |
| Foreign Institutional Investors (FII) | 6.74% | 6.57% | 6.42% | 6.84% | 5.09% |
| Public Investors | 10.99% | 10.50% | 10.34% | 10.14% | 10.21% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
ALIVUS Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
543322
NSE Scrip Name
ALIVUS
ISIN
INE03Q201024



